How does cholesterol burden change the case for investing in familial hypercholesterolaemia? A cost-effectiveness analysis
(2022)
Journal Article
Background and aims This study aimed to ascertain how the long-term benefits and costs of diagnosis and treatment of familial hypercholesterolaemia (FH) vary by prognostic factors and ‘cholesterol burden’, which is the effect of long-term exposure t... Read More about How does cholesterol burden change the case for investing in familial hypercholesterolaemia? A cost-effectiveness analysis.